These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 15922743

  • 1. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK, Beauchamp RD, Datta PK.
    Exp Cell Res; 2005 Jul 01; 307(1):231-46. PubMed ID: 15922743
    [Abstract] [Full Text] [Related]

  • 2. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Büchler MW, Falb D, Korc M.
    Oncogene; 1999 Sep 23; 18(39):5363-72. PubMed ID: 10498890
    [Abstract] [Full Text] [Related]

  • 3. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
    Halder SK, Anumanthan G, Maddula R, Mann J, Chytil A, Gonzalez AL, Washington MK, Moses HL, Beauchamp RD, Datta PK.
    Cancer Res; 2006 Jun 15; 66(12):6156-66. PubMed ID: 16778189
    [Abstract] [Full Text] [Related]

  • 4. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
    Hummer BT, Bartlett C, Henry E, Weissman BE.
    J Cell Physiol; 2003 Mar 15; 194(3):289-302. PubMed ID: 12548549
    [Abstract] [Full Text] [Related]

  • 5. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 6. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ.
    Clin Cancer Res; 2002 Nov 28; 8(11):3628-38. PubMed ID: 12429655
    [Abstract] [Full Text] [Related]

  • 7. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, Inamoto T, Takahara S, Itoh Y, Otsuki Y, Katsuoka Y, Miyazono K, Horie S.
    J Natl Cancer Inst; 2005 Dec 07; 97(23):1734-46. PubMed ID: 16333029
    [Abstract] [Full Text] [Related]

  • 8. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
    Fink SP, Swinler SE, Lutterbaugh JD, Massagué J, Thiagalingam S, Kinzler KW, Vogelstein B, Willson JK, Markowitz S.
    Cancer Res; 2001 Jan 01; 61(1):256-60. PubMed ID: 11196171
    [Abstract] [Full Text] [Related]

  • 10. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY, Hu YC, He XR, Wang Y, Song BQ, Zhou PK, Zhu MX, Li G, Wu DC.
    Cell Biol Toxicol; 2007 Mar 01; 23(2):113-28. PubMed ID: 17096210
    [Abstract] [Full Text] [Related]

  • 11. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A.
    Cancer Res; 2003 Nov 15; 63(22):7760-8. PubMed ID: 14633701
    [Abstract] [Full Text] [Related]

  • 12. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
    Nagarajan RP, Chen F, Li W, Vig E, Harrington MA, Nakshatri H, Chen Y.
    Biochem J; 2000 Jun 15; 348 Pt 3(Pt 3):591-6. PubMed ID: 10839991
    [Abstract] [Full Text] [Related]

  • 13. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
    Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG.
    Mol Cell Biol; 2007 Jun 15; 27(12):4488-99. PubMed ID: 17438144
    [Abstract] [Full Text] [Related]

  • 14. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.
    Kuga H, Morisaki T, Nakamura K, Onishi H, Noshiro H, Uchiyama A, Tanaka M, Katano M.
    Oncogene; 2003 Oct 30; 22(49):7838-47. PubMed ID: 14586410
    [Abstract] [Full Text] [Related]

  • 15. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
    Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Maki K, Ogawa S, Chiba S, Mitani K, Hirai H.
    Oncogene; 2001 Jan 04; 20(1):88-96. PubMed ID: 11244507
    [Abstract] [Full Text] [Related]

  • 16. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
    Iglesias M, Frontelo P, Gamallo C, Quintanilla M.
    Oncogene; 2000 Aug 24; 19(36):4134-45. PubMed ID: 10962574
    [Abstract] [Full Text] [Related]

  • 17. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
    He WX, Niu ZY, Zhao SL, Smith AJ.
    Arch Oral Biol; 2005 Nov 24; 50(11):929-36. PubMed ID: 16183370
    [Abstract] [Full Text] [Related]

  • 18. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
    Javelaud D, Delmas V, Möller M, Sextius P, André J, Menashi S, Larue L, Mauviel A.
    Oncogene; 2005 Nov 17; 24(51):7624-9. PubMed ID: 16007121
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S, Goldschmidt-Clermont PJ, Dong C.
    Circ Res; 2004 Mar 19; 94(5):617-25. PubMed ID: 14739161
    [Abstract] [Full Text] [Related]

  • 20. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
    O'Rear L, Longobardi L, Torello M, Law BK, Moses HL, Chiarelli F, Spagnoli A.
    J Mol Endocrinol; 2005 Jun 19; 34(3):723-37. PubMed ID: 15956343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.